MEDI-4276

N/A

Report date: 2024/02/05 13:50:47

Base Information

Drug NameMEDI-4276

Drug Alias NameMEDI-4276

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linker > MC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > AZ13599185 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-HER2

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMedimmune Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedimmune Llc

Active IndicationsN/A

Inactive IndicationsStomach NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A